British Journal of Haematology

Papers
(The H4-Index of British Journal of Haematology is 34. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-08-01 to 2025-08-01.)
ArticleCitations
e‐Posters125
Graham Serjeant, Sickle Cell, Jamaica and Beyond: A Life, Ian Randle Publishers (Kingston and Miami), 2021122
Don't forget cord blood in non‐remission acute myeloid leukaemia!91
Issue Information86
Issue Information84
Association of biomarkers of endothelial function, coagulation activation and kidney injury with persistent albuminuria in sickle cell anaemia81
Correction to “Cytidine deaminase status as a marker of response to azacytidine treatment in MDS and AML patients”79
How to dose and monitor argatroban for treatment of HIT71
63
CAR T in patients with large B‐cell lymphoma not fit for autologous transplant60
A 4‐gene prognostic index for enhancing acute myeloid leukaemia survival prediction60
Characterisation of two tumour cell populations in the small cell variant of anaplastic lymphoma kinase‐positive anaplastic large cell lymphoma57
MYC‐induced cytidine metabolism regulates survival and drug resistance via cGas‐STING pathway in mantle cell lymphoma54
Immunophenotypic clustering in paediatric acute myeloid leukaemia54
Issue Information53
A novel PML germline variant as a candidate predisposing genetic aberration in familial acute myeloid leukaemia50
R‐CHOP treatment for patients with advanced follicular lymphoma: Over 15‐year follow‐up of JCOG020350
Venous thromboembolism incidence associated with pegylated asparaginase (ASP) compared to the native L‐ASP: A retrospective analysis with an ASP‐based protocol in adult patients with acute lympho49
Inhibition of the Sec61 translocon overcomes cytokine‐induced glucocorticoid resistance in T‐cell acute lymphoblastic leukaemia49
Identification and management of preoperative anaemia in adults: A British Society for Haematology Guideline update48
Population‐based cohort study of the efficacy of brentuximab vedotin in relapsed systemic anaplastic large‐cell lymphoma using Public Health England data47
Erythrophagocytosis in a patient with myelodysplastic syndrome with excess blasts‐1 with isolated del(6q)45
Haematopoietic stem cell mobilisation followed by high‐dose chemotherapy and autologous stem cell transplantation for patients with sickle cell disease and myeloma42
Applying current smouldering myeloma risk models to a UK single‐centre cohort and clinical features at progression42
The impact of COVID‐19 vaccination on patients with a history of heparin‐induced thrombocytopenia41
The significance of mixed chimaerism and cell lineage chimaerism monitoring in paediatric patients post haematopoietic stem cell transplant39
Stratified management based on surface antibody for the prevention of hepatitis B virus reactivation in lymphoma patients39
Late recurrence of lymphoid malignancies after initial treatment for Hodgkin lymphoma – A study from the Danish Lymphoma Registry38
Functional impairment of erythropoiesis in Congenital Dyserythropoietic Anaemia type I arises at the progenitor level38
Myelodysplastic syndrome associated‐haemophagocytic lymphohistiocytosis: A retrospective study of 15 cases in a single centre38
Antibody response to a third SARS‐CoV‐2 vaccine dose in recipients of an allogeneic haematopoietic cell transplantation36
Venetoclax ramp‐up strategies for chronic lymphocytic leukaemia in the United Kingdom: a real world multicentre retrospective study36
Use of dipyridamole is associated with lower risk of lymphoid neoplasms: a propensity score‐matched cohort study35
Transcriptional and genomic characterization of measurable residual disease in acute myeloid leukaemia35
Does eventually NPM1 mutation in blast phase chronic myeloid leukemia (BP‐CML) exist? That is the question.34
Liquid biopsy in Hodgkin lymphoma – moving beyond the proof of principle34
0.10570383071899